Medbright AI Investments Inc C.MBAI

MBAI Appoints Limmi Co-Founder as CEO

[MarketMakerss]

With a bullish setup, MedBright AI (MBAI.c MBAIF) is up 10% with above-average volume on the news of Trevor Vieweg's appointment as Chief Executive Officer.

 

Previously serving as the Head of Product Development at Viasat (NASDAQ:VSAT, 3.4 BILLION mcap) and as the Chief Technology Office of Sea Machines Robotics, a venture-backed AI and robotics start-up, Vieweg "brings a tremendous amount of experience and understanding of how companies commercialize AI at scale in a diverse set of markets”

 

Additionally, Vieweg is an investor and co-founder of Limmi Healthcare AI Platform, an artificial intelligence platform focused on powering complex healthcare data analytics systems.

 

MBAI Chairman, Jaime Gerber, commented:

“The combination of Trevor’s AI and commercial expertise coupled with our strong healthcare team is the perfect match for our aim of monetizing artificial intelligence investment opportunities that can change how healthcare is delivered globally.”

 

This news comes after the latest critical move for the development of MBAI's MedMatrix, MBAI making their own investment into Limmi.

 

MedMatrix leverages artificial intelligence to assess crucial aspects of healthcare facilities to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic. Attesting to its strength as a platform, one of MBAI's beta customers is a Yale University School of Medicine affiliated clinic group

 

In exchange for Limmi granting MBAI certain rights to the Limmi Artificial Intelligence FDA and HIPAA Platform, MBAI issued 350 common shares of MB Acquisition Co to Limmi. Notably, the shares issues likely won't come into free trading for over two years, demonstrating MBAI's commitment to protecting existing shareholders.

 

Additionally, pursuant to the IP License and Option Agreement, Limmi granted the "binding and irrevocable option" to purchase the Limmi AI Platform.

 

Incorporating this platform into MBAI's MedMatrix marks a significant development for the platform as MedMatrix, an industry-leading AI-powered data analytics platform, leverages artificial intelligence to assess crucial aspects of healthcare facilities to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic while reducing physician burnout and improving patient satisfaction.

 

Full News Release: https://financialpost.com/globe-newswire/medbright-ai-appoints-trevor-vieweg-as-chief-executive-officer

 

Posted on Behalf of MedBright AI Investments Inc.